1. Li Zhou, Bin Yu, Mengqiu Gao, Rui Chen, Zhiyu Li, Yueqing Gu*, Jinlei Bian*, Yi Ma*. DNA framework-engineered chimeras platform enables selectively targeted protein degradation. Nature Communications, 2023, 14(1): 4510.
2. Wen Li#, Jiali Huang#, Chen Shen#, Weiye Jiang, Xi Yang, Jingxuan Huang, Yueqing Gu, Zhiyu Li*, Yi Ma*, Jinlei Bian*. Tumor-targeted metabolic inhibitor prodrug labelled with cyanine dyes enhances immunoprevention of lung cancer. Acta Pharmaceutica Sinica B, 2023, 14(2): 751-764.
3. Yi Ma#, Yuxuan Ma#, Mengqiu Gao, Zhihao Han, Wen Jiang, Yueqing Gu*, Yi Liu*. Platelet-Mimicking Therapeutic System for Noninvasive Mitigation of the Progression of Atherosclerotic Plaques. Advanced Science, 2021, 8(8): 2004128.
4. Ping Li, Qi Chang, Mengmeng Liu, Ke Lei, Shuai Ping, Jia Wang, Yueqing Gu*, He Ren*, Yi Ma*. DNA-Encoded and Spatial Proximity Replaced Glycoprotein Analysis Reveals Glycosylation Heterogeneity of Extracellular Vesicles. Analytical Chemistry, 2023, 95(48): 17467-17476.
5. Yi Ma#, Zhaohui Wang#, Yuxuan Ma, Zhihao Han, Min Zhang, Haiyan Chen* and Yueqing Gu*. A Telomerase‐Responsive DNA Icosahedron for Precise Delivery of Platinum Nanodrugs to Cisplatin‐Resistant Cancer. Angewandte ChemieInternational Edition, 2018, 130(19): 5487-5491.